PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
32729248-8	2020	Further top ACE2 regulators in vivo or in primary cells include erlotinib and bleomycin in the lung and vancomycin, cisplatin, and probenecid in the kidney.	Bleomycin	78-87	angiotensin converting enzyme 2	Homo sapiens	12-16	
18441099-9	2008	Moreover, purified recombinant human ACE-2, delivered to mice systemically by osmotic minipump, attenuated bleomycin-induced lung collagen accumulation.	Bleomycin	107-116	angiotensin converting enzyme 2	Homo sapiens	37-42	
33706759-8	2021	ACE2 and TMPRSS2 were also expressed in FSP-1+ lung fibroblasts in bleomycin-induced pulmonary fibrosis, and when combined with PM exposure, they were further upregulated.	Bleomycin	67-76	angiotensin converting enzyme 2	Homo sapiens	0-4	
25435005-0	2015	Therapeutic effect of human umbilical cord mesenchymal stem cells modified by angiotensin-converting enzyme 2 gene on bleomycin-induced lung fibrosis injury.	Bleomycin	118-127	angiotensin converting enzyme 2	Homo sapiens	78-109	
29731719-8	2018	ACE2 or vehicle was administered via osmotic pump for the final 2 weeks, beginning 3 weeks after bleomycin.	Bleomycin	97-106	angiotensin converting enzyme 2	Homo sapiens	0-4	
29731719-13	2018	Conclusion: Collectively, our findings enumerate that ACE2 treatment improved pulmonary vascular muscularization following bleomycin exposure, concomitant with increased SOD2 expression.	Bleomycin	123-132	angiotensin converting enzyme 2	Homo sapiens	54-58	
25435005-1	2015	The aim of the present study was to evaluate the therapeutic effects of human umbilical cord mesenchymal stem cells (uMSCs) in the presence of angiotensin-converting enzyme 2 gene (ACE2; ACE2-uMSCs) on bleomycin (BLM)-induced lung injury and pulmonary fibrosis in mice.	Bleomycin	202-211	angiotensin converting enzyme 2	Homo sapiens	143-174	
25435005-1	2015	The aim of the present study was to evaluate the therapeutic effects of human umbilical cord mesenchymal stem cells (uMSCs) in the presence of angiotensin-converting enzyme 2 gene (ACE2; ACE2-uMSCs) on bleomycin (BLM)-induced lung injury and pulmonary fibrosis in mice.	Bleomycin	202-211	angiotensin converting enzyme 2	Homo sapiens	181-185	
25435005-1	2015	The aim of the present study was to evaluate the therapeutic effects of human umbilical cord mesenchymal stem cells (uMSCs) in the presence of angiotensin-converting enzyme 2 gene (ACE2; ACE2-uMSCs) on bleomycin (BLM)-induced lung injury and pulmonary fibrosis in mice.	Bleomycin	202-211	angiotensin converting enzyme 2	Homo sapiens	187-191	
25435005-1	2015	The aim of the present study was to evaluate the therapeutic effects of human umbilical cord mesenchymal stem cells (uMSCs) in the presence of angiotensin-converting enzyme 2 gene (ACE2; ACE2-uMSCs) on bleomycin (BLM)-induced lung injury and pulmonary fibrosis in mice.	Bleomycin	213-216	angiotensin converting enzyme 2	Homo sapiens	143-174	
25435005-1	2015	The aim of the present study was to evaluate the therapeutic effects of human umbilical cord mesenchymal stem cells (uMSCs) in the presence of angiotensin-converting enzyme 2 gene (ACE2; ACE2-uMSCs) on bleomycin (BLM)-induced lung injury and pulmonary fibrosis in mice.	Bleomycin	213-216	angiotensin converting enzyme 2	Homo sapiens	181-185	
25435005-1	2015	The aim of the present study was to evaluate the therapeutic effects of human umbilical cord mesenchymal stem cells (uMSCs) in the presence of angiotensin-converting enzyme 2 gene (ACE2; ACE2-uMSCs) on bleomycin (BLM)-induced lung injury and pulmonary fibrosis in mice.	Bleomycin	213-216	angiotensin converting enzyme 2	Homo sapiens	187-191	
25435005-6	2015	In conclusion, the results of the present study demonstrated that ACE2 and uMSCs had a synergistic therapeutic effect on bleomycin-induced acute lung injury.	Bleomycin	121-130	angiotensin converting enzyme 2	Homo sapiens	66-70	
25089563-10	2015	In vivo, constant infusion with Ang(1-7) or intratracheal instillation with lenti-ACE2 shifted the RAS balance toward the ACE2/Ang(1-7)/Mas axis, alleviated bleomycin-induced lung fibrosis, and inhibited the RhoA/Rock pathway by reducing NOX4-derived ROS.	Bleomycin	157-166	angiotensin converting enzyme 2	Homo sapiens	82-86	
24168260-4	2014	We hypothesized that up-regulation of the ACE2/Ang-(1-7)/Mas axis protects against bleomycin (BLM)-induced pulmonary fibrosis by inhibiting the mitogen-activated protein kinase (MAPK)/NF-kappaB pathway.	Bleomycin	83-92	angiotensin converting enzyme 2	Homo sapiens	42-46	
24168260-4	2014	We hypothesized that up-regulation of the ACE2/Ang-(1-7)/Mas axis protects against bleomycin (BLM)-induced pulmonary fibrosis by inhibiting the mitogen-activated protein kinase (MAPK)/NF-kappaB pathway.	Bleomycin	94-97	angiotensin converting enzyme 2	Homo sapiens	42-46